Definitive Healthcare Q3 revenue $60M (-4% YoY); net loss $17.8M; raises FY revenue guidance low end

Definitive Healthcare Corp.

2025-Q3 EPS reported -$1.20 revenue$179,987,000

Revenue $60.0M (-4% vs $62.7M in Q3 2024); net loss $17.8M (vs $187.8M including $228.2M goodwill impairment).
Adjusted EBITDA $18.9M (32% margin), down from $20.6M (33% margin) YoY; adjusted net income $9.7M.
Q4 2025 revenue guidance $59-60M; FY 2025 revenue guidance raised to $239-240M (low end up $2M).
Customer wins: large biopharma and medical device company selected Definitive Healthcare for commercial intelligence.
Cash flow from operations $15.7M; unlevered free cash flow $17.9M in Q3 2025.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.